LAVA Therapeutics N.V.LAVA Therapeutics N.V.LAVA Therapeutics N.V.

LAVA Therapeutics N.V.

No trades
See on Supercharts

Price target

2.330.000.00%
The 3 analysts offering 1 year price forecasts for LVTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to LVTX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


LVTX EPS for the last quarter is −0.46 USD despite the estimation of −0.33 USD. In the next quarter EPS is expected to reach −0.30 USD. Track more of LAVA Therapeutics N.V. financials and stay on top of what is up with the company.
In the next quarter LAVA Therapeutics N.V. revenue is expected to reach ‪2.50 M‬ USD. Check out LAVA Therapeutics N.V. revenue and earnings and make informed decisions.
According to analysts, LVTX price target is 2.33 USD with a max estimate of 3.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch LAVA Therapeutics N.V. stock price chart and keep track of the current situation with LVTX news and stock market news.